Glucaric acid

Glucaric acid is a lipid of Fatty Acyls (FA) class. Glucaric acid is associated with abnormalities such as Consumption-archaic term for TB and furuncle. The involved functions are known as Oxidation, Mutation, Process, Cell Growth and Anabolism. Glucaric acid often locates in BL21, Clone and host. The associated genes with Glucaric acid are MIOX gene, ISYNA1 gene, Genome and Candidate Disease Gene. The related experimental models are Knock-out.

Cross Reference

Introduction

To understand associated biological information of Glucaric acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Glucaric acid?

Glucaric acid is suspected in and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Glucaric acid

MeSH term MeSH ID Detail
Parkinson Disease D010300 53 associated lipids
von Willebrand Diseases D014842 2 associated lipids
Ascorbic Acid Deficiency D001206 9 associated lipids
Micronuclei, Chromosome-Defective D048629 33 associated lipids
Atherosclerosis D050197 85 associated lipids
Insulin Resistance D007333 99 associated lipids
Dehydration D003681 11 associated lipids
Renal Insufficiency, Chronic D051436 9 associated lipids
Critical Illness D016638 13 associated lipids
Anemia, Iron-Deficiency D018798 6 associated lipids
Myocardial Stunning D017682 10 associated lipids
Postoperative Hemorrhage D019106 7 associated lipids
Carcinogenesis D063646 3 associated lipids
Blood Loss, Surgical D016063 6 associated lipids
Restless Legs Syndrome D012148 2 associated lipids
Iron Overload D019190 11 associated lipids
Anemia, Refractory D000753 3 associated lipids
Calcium Metabolism Disorders D002128 1 associated lipids
Anemia, Neonatal D000751 1 associated lipids
Gilbert Disease D005878 2 associated lipids
Per page 10 20 50 100 | Total 85

PubChem Associated disorders and diseases

What pathways are associated with Glucaric acid

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Glucaric acid through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Glucaric acid?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Glucaric acid?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Glucaric acid?

There are no associated biomedical information in the current reference collection.

What genes are associated with Glucaric acid?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Glucaric acid?

Knock-out

Knock-out are used in the study 'Evolution-guided optimization of biosynthetic pathways.' (Raman S et al., 2014).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Glucaric acid

Download all related citations
Per page 10 20 50 100 | Total 1061
Authors Title Published Journal PubMed Link
Okada DR et al. Early detection of infarct in reperfused canine myocardium using 99mTc-glucarate. 2004 J. Nucl. Med. pmid:15073263
Willerson JT Detection of acute myocardial infarcts by infarct-avid imaging. 1991 J. Nucl. Med. pmid:1846912
Liu Z et al. High-resolution imaging with (99m)Tc-glucarate for assessing myocardial injury in rat heart models exposed to different durations of ischemia with reperfusion. 2004 J. Nucl. Med. pmid:15235074
Kochhar PK et al. Intravenous iron sucrose versus oral iron in treatment of iron deficiency anemia in pregnancy: a randomized clinical trial. 2013 J. Obstet. Gynaecol. Res. pmid:22925176
Devasenapathy N et al. Is intravenous iron sucrose the treatment of choice for pregnant anemic women? 2013 J. Obstet. Gynaecol. Res. pmid:23167561
Krafft A and Breymann C Iron sucrose with and without recombinant erythropoietin for the treatment of severe postpartum anemia: a prospective, randomized, open-label study. 2011 J. Obstet. Gynaecol. Res. pmid:21159035
Gehret TC et al. Convenient large-scale synthesis of D-glucaro-1,4:6,3-dilactone. 2009 J. Org. Chem. pmid:19777999
Cassimos C et al. Urinary D-glucaric acid excretion in children with dystonic reactions caused by antiemetic drugs. 1975 J. Pediatr. pmid:1185409
Cassimos C et al. Urinary D-glucaric acid excretion in normal and G-6-PD-deficient children with favism. 1974 J. Pediatr. pmid:4826626
Meyer MP et al. A comparison of oral and intravenous iron supplementation in preterm infants receiving recombinant erythropoietin. 1996 J. Pediatr. pmid:8765624
Fujimoto T et al. A new clinical prognostic predictor for patients with biliary atresia. 1994 J. Pediatr. Surg. pmid:8078014
Garnham JC et al. The effect of repeated administration of diftalone on enzyme induction. 1978 J. Pharm. Pharmacol. pmid:27604
Oleson L and Court MH Effect of the beta-glucuronidase inhibitor saccharolactone on glucuronidation by human tissue microsomes and recombinant UDP-glucuronosyltransferases. 2008 J. Pharm. Pharmacol. pmid:18718121
Latham AN D-Glucaric acid as an index of hepatic enzyme induction by anticonvulsant drugs in man. 1974 J. Pharm. Pharmacol. pmid:4151390
Latham AN Effect of in vitro changes in urinary pH on the enzymatic measurement and daily variation in excretion of D-glucaric acid. 1975 J. Pharm. Pharmacol. pmid:239180
Tanaka E et al. Studies on the trimethadione metabolism as a tool for the assessment of drug-metabolizing capacity using plasma and urine of rats pretreated with phenobarbital and 3-methylcholanthrene. 1982 J. Pharmacobio-dyn. pmid:7097483
Bologa M et al. Pregnancy-induced changes in drug metabolism in epileptic women. 1991 J. Pharmacol. Exp. Ther. pmid:2033516
Patel IH et al. Induction effect of phenobarbital on the carbamazepine to carbamazepine-10, 11-epoxide pathway in rhesus monkeys. 1981 J. Pharmacol. Exp. Ther. pmid:7229992
Tutor-Crespo MJ et al. Effect of antiepileptic drugs on the urinary excretion of porphyrins in non-porphyric subjects. 2005 J. Pharmacol. Sci. pmid:16314692
Kolodziejczyk J et al. In vitro study of the antioxidative properties of the glucose derivatives against oxidation of plasma components. 2011 J. Physiol. Biochem. pmid:21086198
Kaltwasser JP et al. Effect of recombinant human erythropoietin and intravenous iron on anemia and disease activity in rheumatoid arthritis. 2001 J. Rheumatol. pmid:11708414
Wang Y et al. Hepatoprotective effects of kombucha tea: identification of functional strains and quantification of functional components. 2014 J. Sci. Food Agric. pmid:23716136
Yamamoto S et al. Iatrogenic osteomalacia: report of two cases. 2013 J. UOEH pmid:23475021
Lynn S and McDaniel J Managing severe anemia when the patient is a Jehovah's Witness. 2013 JAAPA pmid:23610833
Gorder V et al. Treatment of restless legs syndrome with iron infusion therapy. 2009 JAAPA pmid:19354112
Smith TG et al. Effects of iron supplementation and depletion on hypoxic pulmonary hypertension: two randomized controlled trials. 2009 JAMA pmid:19809026
Adhikary L and Acharya S Efficacy of IV iron compared to oral iron for increment of haemoglobin level in anemic chronic kidney disease patients on erythropoietin therapy. 2011 Jul-Sep JNMA J Nepal Med Assoc pmid:22922860
Tsuruoka T et al. Inhibition of pulmonary metastases and tumor cell invasion in experimental tumors by sodium D-glucaro-delta-lactam (ND2001). 1995 Jpn. J. Cancer Res. pmid:7737908
Tsuruoka T et al. Inhibition of tumor cell haptotaxis by sodium D-glucaro-delta-lactam (ND2001). 1995 Jpn. J. Cancer Res. pmid:8567400
Furuno K et al. Influence of dehydration and D-glucarate on distribution and excretion of kanamycin in rats. 1977 Jpn. J. Pharmacol. pmid:916384
Furuno K et al. Effect of D-glucaric acid derivatives on stability of rat liver lysosomes and erythrocytes. 1974 Jpn. J. Pharmacol. pmid:4463271
Hinohara Y et al. Glucuronic acid pathway in alloxan diabetic rabbits. (I). Urinary excretion of metabolites related to the glucuronic acid pathway. 1974 Jpn. J. Pharmacol. pmid:4463273
Higashi T et al. [Relative Ga-67 image enhancement by iron-loading]. 1984 Kaku Igaku pmid:6593479
Tanaka H et al. [A growth media of genus Legionella in containing saccharated ferric oxide (Fesin) replacing soluble ferric pyrophosphate (author's transl)]. 1982 Kansenshogaku Zasshi pmid:6809855
Almilaji A et al. Regulation of the voltage gated K channel Kv1.3 by recombinant human klotho protein. 2014 Kidney Blood Press. Res. pmid:25571875
Keven K et al. Combination of intravenous iron sucrose and ascorbic acid in hemodialysis patients. 2005 Kidney Int. pmid:15954940
Agarwal R Is i.v. iron really superior in CKD patients not on dialysis? 2006 Kidney Int. pmid:16957750
Zager RA Parenteral iron treatment induces MCP-1 accumulation in plasma, normal kidneys, and in experimental nephropathy. 2005 Kidney Int. pmid:16164630
Agarwal R Proinflammatory effects of iron sucrose in chronic kidney disease. 2006 Kidney Int. pmid:16609688
Deicher R et al. High-dose parenteral iron sucrose depresses neutrophil intracellular killing capacity. 2003 Kidney Int. pmid:12846772
Agarwal R Transferrin saturation with intravenous irons: an in vitro study. 2004 Kidney Int. pmid:15327409
Aronoff GR et al. Iron sucrose in hemodialysis patients: safety of replacement and maintenance regimens. 2004 Kidney Int. pmid:15327417
Zager RA et al. Parenteral iron nephrotoxicity: potential mechanisms and consequences. 2004 Kidney Int. pmid:15200421
Zager RA et al. Combined iron sucrose and protoporphyrin treatment protects against ischemic and toxin-mediated acute renal failure. 2016 Kidney Int. pmid:27165818
Agarwal R et al. A randomized trial of intravenous and oral iron in chronic kidney disease. 2015 Kidney Int. pmid:26083656
Vikrant S Optimum dosage regimen for iron sucrose. 2007 Kidney Int. pmid:17625585
Jaber BL Iron sucrose causes greater proteinuria than ferric gluconate in non-dialysis chronic kidney disease. 2008 Kidney Int. pmid:18235527
Lim R et al. A permanent tan from iron. 2008 Kidney Int. pmid:18340355
Auerbach M and Al Talib K Low-molecular weight iron dextran and iron sucrose have similar comparative safety profiles in chronic kidney disease. 2008 Kidney Int. pmid:18274543
Schaller G et al. Intravenous iron increases labile serum iron but does not impair forearm blood flow reactivity in dialysis patients. 2005 Kidney Int. pmid:16316358